2021 AHNS International Conference on Head and Neck Cancer
Avoid Potential Irritants: Check for allergens such as fragrance, dyes, or preservatives
Tomiyasu H, Goto-Koshino Y, Takahashi M, Fujino Y, Ohno K, Tsujimoto H
Substance use disorder GLP-1 agonists are postulated as potential treatments for substance use disorders
"With the positive results from TRIUMPH-2 and TRIUMPH-3, we now have the clinical data package to support global submissions for retatrutide as a potential treatment for obesity, knee osteoarthritis pain, and obstructive sleep apnea
While the primary use of GLP-1 agonists has been in managing diabetes and obesity, their impact on the brain's reward pathways has opened new avenues for their application in mental health and substance use treatment